Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease

Summary

This is a phase 1 randomized, double-blind, single ascending dose (SAD) and multiple ascending dose (MAD) study to assess the safety, tolerability, and Pharmacokinetics (PK) of single and multiple ascending doses of MTX-439 administered in healthy adults and adults with diabetic kidney disease (DKD)

Timeline

Start

2026-05-19

Primary completion

2027-05

Completion

2028-01

Drugs

Indications